144 related articles for article (PubMed ID: 15754629)
1. [Role of interleukin-18, interleukin-1beta and its soluble receptor (sIL-1RII) in early and late Lyme borreliosis].
Pietruczuk A; Swierzbińska R; Pietruczuk M; Hermanowska-Szpakowicz T
Pol Merkur Lekarski; 2004 Nov; 17(101):446-50. PubMed ID: 15754629
[TBL] [Abstract][Full Text] [Related]
2. [Concentration of interleukin-18, interleukin-1beta, soluble receptor for interleukin-1 (sIL-1RII) and C-reactive protein in patients with neuroborreliosis].
Pietruczuk A; Swierzbińska R; Pietruczuk M; Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
Neurol Neurochir Pol; 2005; 39(1):33-9. PubMed ID: 15735988
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of interleukin-18 (IL-18), interleukin-1beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis.
Pietruczuk A; Swierzbińska R; Pancewicz S; Pietruczuk M; Hermanowska-Szpakowicz T
Infection; 2006 Jun; 34(3):158-62. PubMed ID: 16804660
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (il-8) in lyme borreliosis.
Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Rwierzbińska R; Hermanowska-Szpakowicz T
Infection; 2004 Dec; 32(6):350-5. PubMed ID: 15597225
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
Jouvenne P; Vannier E; Dinarello CA; Miossec P
Arthritis Rheum; 1998 Jun; 41(6):1083-9. PubMed ID: 9627018
[TBL] [Abstract][Full Text] [Related]
6. IL-1 beta, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders.
Tominaga K; Habu M; Sukedai M; Hirota Y; Takahashi T; Fukuda J
Arch Oral Biol; 2004 Jun; 49(6):493-9. PubMed ID: 15099807
[TBL] [Abstract][Full Text] [Related]
7. [Concentrations of pro-inflammatory cytokines IFN-gamma, IL-6, IL-12 and IL-15 in serum and cerebrospinal fluid in patients with neuroborreliosis undergoing antibiotic treatment].
Pancewicz SA; Kondrusik M; Zajkowska J; Grygorczuk S
Pol Merkur Lekarski; 2007 Apr; 22(130):275-9. PubMed ID: 17684925
[TBL] [Abstract][Full Text] [Related]
8. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.
Lindberg C; Chromek M; Ahrengart L; Brauner A; Schultzberg M; Garlind A
Neurochem Int; 2005 Jun; 46(7):551-7. PubMed ID: 15843049
[TBL] [Abstract][Full Text] [Related]
10. Effect of IL-18 on IL-1beta and sIL-1RII production by human neutrophils.
Jabłońska E; Izycka A; Wawrusiewicz N
Arch Immunol Ther Exp (Warsz); 2002; 50(2):139-41. PubMed ID: 12022703
[TBL] [Abstract][Full Text] [Related]
11. Soluble IL-1RII and IL-18 are associated with incipient upper extremity soft tissue disorders.
Rechardt M; Shiri R; Matikainen S; Viikari-Juntura E; Karppinen J; Alenius H
Cytokine; 2011 May; 54(2):149-53. PubMed ID: 21371906
[TBL] [Abstract][Full Text] [Related]
12. Profile of soluble cytokine receptors in Crohn's disease.
Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
14. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
Grygorczuk S; Zajkowska J; Swierzbińska R; Pancewicz S; Kondrusik M; Hermanowska-Szpakowicz T
Rocz Akad Med Bialymst; 2005; 50():173-8. PubMed ID: 16358960
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis.
Bellehumeur C; Collette T; Maheux R; Mailloux J; Villeneuve M; Akoum A
Hum Reprod; 2005 May; 20(5):1177-84. PubMed ID: 15705625
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
17. Effect of IL-15 on the secretion of IL-1beta, IL-1Ra and sIL-1RII by PMN from cancer patients.
Jablonska E; Piotrowski L; Kiluk M; Jablonski J; Grabowska Z; Markiewicz W
Cytokine; 2001 Dec; 16(5):173-7. PubMed ID: 11814312
[TBL] [Abstract][Full Text] [Related]
18. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome.
Widhe M; Jarefors S; Ekerfelt C; Vrethem M; Bergstrom S; Forsberg P; Ernerudh J
J Infect Dis; 2004 May; 189(10):1881-91. PubMed ID: 15122525
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]